A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography:: Comparison of physicochemical properties and the in vivo behaviour

被引:71
作者
Lind, K
Kresse, M
Debus, NP
Müller, RH
机构
[1] Free Univ Berlin, Dept Pharmaceut Technol, D-12169 Berlin, Germany
[2] Schering AG, D-13342 Berlin, Germany
[3] Inst Diagnost Res, D-14050 Berlin, Germany
关键词
MR lymphography; starch; superparamagnetic iron oxides; blood half-life;
D O I
10.1080/10611860290022651
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The major aim of this study was to prove or disprove the theories concerning the correlation between physicochemical properties of superparamagnetic iron oxide (SPIO) particles and their accumulation in the lymph nodes. New SPIO particles were produced using starch as stabilising polymer shell. The synthesis was done in a two-step procedure using conventional wet-chemical precipitation technique and subsequent coating of the iron oxide cores. The particles were physicochemically characterised and their lymphotrophy studied in rats using well described lymphotropic dextran-coated SPIO particles as reference. Despite the short blood half-lives of approximately 13 min and the relatively large sizes (approximately 60-90 nm), the starch SPIO particles proved at least as efficient in lymph node accumulation as the small 25 nm dextran SPIO particles having a half-life of 90 min. The currently accepted theories concerning the connection between particle properties and their uptake into lymph nodes are not generally valid, or have at least to be limited for dextran-coated SPIO particles. Lymph node targeting could be achieved despite the present theories consider small size (< 30 nm) and long circulation times in the blood as prerequisites. Histological examination showed, that SPIO particles could only be found in lymph node areas where macrophages could be marked which enclosed the particles. Localisation in marginal areas of the lymph nodes indicates endothelial transcytosis as the major accumulation pathway.
引用
收藏
页码:221 / 230
页数:10
相关论文
共 50 条
[1]   INITIAL CLINICAL-EXPERIENCE WITH DEXTRAN-COATED SUPERPARAMAGNETIC IRON-OXIDE FOR DETECTION OF LYMPH-NODE METASTASES IN PATIENTS WITH HEAD AND NECK-CANCER [J].
ANZAI, Y ;
BLACKWELL, KE ;
HIRSCHOWITZ, SL ;
ROGERS, JW ;
SATO, Y ;
YUH, WTC ;
RUNGE, VM ;
MORRIS, MR ;
MCLACHLAN, SJ ;
LUFKIN, RB .
RADIOLOGY, 1994, 192 (03) :709-715
[2]  
ANZAI Y, 1994, AM J NEURORADIOL, V15, P87
[3]  
Bean C. P., 1959, J APPL PHYS, V30, p120s, DOI [10.1063/1.2185850, DOI 10.1063/1.2185850]
[4]   Lymph node metastases: Safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles - Initial clinical experience [J].
Bellin, MF ;
Roy, C ;
Kinkel, K ;
Thoumas, D ;
Zaim, S ;
Vanel, D ;
Tuchmann, C ;
Richard, F ;
Jacqmin, D ;
Delcourt, A ;
Challier, E ;
Lebret, T ;
Cluzel, P .
RADIOLOGY, 1998, 207 (03) :799-808
[5]   Magnetic ion-exchange nano- and microparticles for medical, biochemical and molecular biological applications [J].
Bergemann, C ;
Müller-Schulte, D ;
Oster, J ;
à Brassard, L ;
Lübbe, AS .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 1999, 194 (1-3) :45-52
[6]  
BERGEMANN C, 1996, Patent No. 19624426
[7]   Development of superparamagnetic nanoparticles for MRI: Effect of particle size, charge and surface nature on biodistribution [J].
Chouly, C ;
Pouliquen, D ;
Lucet, I ;
Jeune, JJ ;
Jallet, P .
JOURNAL OF MICROENCAPSULATION, 1996, 13 (03) :245-255
[8]   MICROSPHERES FOR TARGETING DRUGS TO SPECIFIC BODY SITES [J].
DAVIS, SS ;
ILLUM, L ;
MOGHIMI, SM ;
DAVIES, MC ;
PORTER, CJH ;
MUIR, IS ;
BRINDLEY, A ;
CHRISTY, NM ;
NORMAN, ME ;
WILLIAMS, P ;
DUNN, SE .
JOURNAL OF CONTROLLED RELEASE, 1993, 24 (1-3) :157-163
[9]  
DAVIS SS, 1981, PHARM TECHNOL, V5, P71
[10]  
DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589